These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 28931574

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hypersociability in the Angelman syndrome mouse model.
    Stoppel DC, Anderson MP.
    Exp Neurol; 2017 Jul; 293():137-143. PubMed ID: 28411125
    [Abstract] [Full Text] [Related]

  • 4. Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3.
    Jiang YH, Pan Y, Zhu L, Landa L, Yoo J, Spencer C, Lorenzo I, Brilliant M, Noebels J, Beaudet AL.
    PLoS One; 2010 Aug 20; 5(8):e12278. PubMed ID: 20808828
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse model.
    Meng L, Person RE, Huang W, Zhu PJ, Costa-Mattioli M, Beaudet AL.
    PLoS Genet; 2013 Aug 20; 9(12):e1004039. PubMed ID: 24385930
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons.
    Huang HS, Allen JA, Mabb AM, King IF, Miriyala J, Taylor-Blake B, Sciaky N, Dutton JW, Lee HM, Chen X, Jin J, Bridges AS, Zylka MJ, Roth BL, Philpot BD.
    Nature; 2011 Dec 21; 481(7380):185-9. PubMed ID: 22190039
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a.
    Meng L, Person RE, Beaudet AL.
    Hum Mol Genet; 2012 Jul 01; 21(13):3001-12. PubMed ID: 22493002
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Persistent neuronal Ube3a expression in the suprachiasmatic nucleus of Angelman syndrome model mice.
    Jones KA, Han JE, DeBruyne JP, Philpot BD.
    Sci Rep; 2016 Jun 16; 6():28238. PubMed ID: 27306933
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA.
    Wolter JM, Mao H, Fragola G, Simon JM, Krantz JL, Bazick HO, Oztemiz B, Stein JL, Zylka MJ.
    Nature; 2020 Nov 16; 587(7833):281-284. PubMed ID: 33087932
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impaired hippocampal plasticity and altered neurogenesis in adult Ube3a maternal deficient mouse model for Angelman syndrome.
    Mardirossian S, Rampon C, Salvert D, Fort P, Sarda N.
    Exp Neurol; 2009 Dec 16; 220(2):341-8. PubMed ID: 19782683
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A high-fidelity RNA-targeting Cas13 restores paternal Ube3a expression and improves motor functions in Angelman syndrome mice.
    Li J, Shen Z, Liu Y, Yan Z, Liu Y, Lin X, Tang J, Lv R, Geng G, Xiong ZQ, Zhou C, Yang H.
    Mol Ther; 2023 Jul 05; 31(7):2286-2295. PubMed ID: 36805082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.